最新ニュース Innventure (NASDAQ:INV) 株価情報

Innventure

Innovaro Inc

AMEX

Innventure Inc creates, funds, operates, and rapidly scales companies in strategic collaboration with MNCs. It provides company creation, corporate strategy, technology optimization, operations, commercialization, and funding. Innventure analyzes the market, including proprietary data provided by MNCs, to identify where their well-protected, breakthrough technologies address market needs and have the potential to create $1B+ in new enterprise value.

Innventure Inc

Inverse Finance - United States dollar

Innoviva Inc

Identiv Inc

Invitation Homes Inc

INTEGRAL VISION INC by Integral Vision, Inc.

Integral Vision Inc

INNOVATIVE CLIMATIC TECH by Innovative Climatic Technologies Corp

INVERITE INSIGHTS INC by Inverite Insights Inc.

Inverite Insights Inc

INVENTECH INVESTMENTS CO by INVENTECH INVESTMENTS CO LTD.

Apollo Power Ltd

Investview Inc

INVESTVIEW INC PFD SER B by Investview Inc.

Indivior PLC ADR

Innovex International Inc

Innoviz Technologies Ltd. - Ordinary shares

Innoviz Technologies Ltd

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.2% points on Monday.
Shares of Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) fell sharply in today's pre-market trading following reports suggesting the company tapped Evercore to raise capital and is considering raising<a href="https://www.benzinga.com/quote/SMCI/news"> equity and debt</a>.
Super Micro Computer shares dipped 12.5% to $31.85 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Tile Shop Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTSH#NASDAQ">TTSH</a>) shares declined 11.5% to $6.10 in pre-market trading.</li>
<li>KalVista Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) fell 7.9% to $8.00 in pre-market trading.</li>
<li>Kearny Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) shares declined 6.5% to $7.51 in pre-market trading.</li>
<li>Innovex International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVX#NASDAQ">INVX</a>) fell 5.8% to $12.52 in pre-market trading.</li>
<li>MAC Copper Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>) fell 5.7% to $11.50 in pre-market trading after declining 4% on Friday.</li>
<li>Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) fell 5.2% to $11.90 in pre-market trading.</li>
<li>Viemed Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMD#NASDAQ">VMD</a>) fell 5% to $8.30 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

INVX

KALV

KRNY

MTAL

SMCI

TTSH

Super Micro Computer And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Accelsius And iM Data Centers Team Up To Introduce Sustainable, High-Performance Cooling Solutions In Miami

Innventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) reported quarterly losses of $(0.94) per share. This is a 11.9 percent decrease over losses of $(0.84) per share from the same period last year. The company reported $317.00 thousand in sales this quarter. This is a 15.69 percent increase over sales of $274.00 thousand the same period last year.

Earnings

Innventure Q3 EPS $(0.94) Down From $(0.84) YoY, Sales $317.00K Up From $274.00K YoY

AFMD

AGAE

AIRI

AKYA

AMAT

AQMS

AREC

ASND

ASTS

AZUL

BENF

BILI

BIOR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BKTI

BKYI

BLUE

BNAI

BNZI

BRAG

BTAI

CASI

CELC

CINT

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CNVS

CRIS

CWCO

DARE

DBGI

DESP

DFLI

DLPN

DMRC

DNMR

DPRO

DTST

EAST

EFXT

ELUT

EWCZ

FLNT

FTLF

GAMB

GAME

GCTS

GDEV

GLOB

HYLN

IMCC

INKT

INTR

ITRM

IVVD

IZEA

LCTX

LIQT

LOCL

LUNR

MITQ

MOVE

MSGM

MUFG

NICE

NOMD

NTES

OCFT

OCUL

OKLO

ONEW

ORGN

PDSB

PHGE

POCI

POST

Earnings Scheduled For November 14, 2024

Innventure Secures $50M Line Of Credit With Western Technology Investment And Raises $11M Through Series B Preferred Stock Issuance To Strengthen Balance Sheet And Enhance Operating Flexibility

WIIM

JNVR

KSPI

LGHL

STEC

VALU

Shares of companies within the broader financial sector are trading lower possibly amid overall market weakness.

U.S. stocks traded lower toward the end of trading, with the S&amp;P 500 falling around 0.4% on Monday.
The Dow traded down 0.87% to 42,901.38 while the NASDAQ slipped 0.03% to 18,484.12. The S&amp;P 500 also fell, dropping, 0.36% to 5,843.72.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41426981/top-4-consumer-stocks-that-may-dip-this-quarter">Top 4 Consumer Stocks That May Dip This Quarter</a>
Leading and Lagging Sectors Information technology shares jumped by 0.4% on Monday.
In trading on Monday, real estate shares fell by 1.9%.
Top Headline
Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) announced that on October 11, it modified its card processing agreement to extend the deadline for its 2025 notes from October 21 to December 23 and the early maturity date from December 31 to March 3.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Viad Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) shares shot up 17% to $41.91 after the company announced it entered into a deal to sell its GES business to Truelink Capital for $535 million.</li>
<li>Shares of Construction Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) got a boost, surging 11% to $83.11 after the company issued FY25 revenue above estimates. Also, Construction Partners announced it will acquire Asphalt Inc for a mix of cash $654 million in cash and 3 million in class A common stock</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares were also up, gaining 75% to $1.77 after the company announced its next-generation SD7 Ultra series 5G mission-critical push-to-talk cellular radio handsets will be available on T-Mobile&#8217;s 5G network.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) shares dropped 14% to $192.77. Sezzle will release its third quarter results after the market close on Nov. 07.</li>
<li>Shares of Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) were down 7% to $11.60.</li>
<li>IGM Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) was down, falling 9% to $15.27.</li>
</ul>
Commodities In commodity news, oil traded up 2.1% to $70.66 while gold traded up 0.3% at $2,739.00.
Silver traded up 2.4% to $34.040 on Monday, while copper fell 0.6% to $4.3595.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.66%, Germany's DAX fell 1% and France's CAC 40 fell 1.01%. Spain's IBEX 35 Index fell 0.71%, while London's FTSE 100 fell 0.48%.
Producer prices in Germany fell 1.4% year-over-year in September compared to a 0.8% decline in the prior two months.
Asia Pacific Markets
Asian markets closed mostly lower on Monday, with Japan's Nikkei 225 falling 0.07%, Hong Kong's Hang Seng Index dipped 1.57%, China's Shanghai Composite Index gaining 0.20% and India's BSE Sensex falling 0.09%.
The People&#8217;s Bank of China cut its one-year loan prime rate by 25bps to 3.1% at the October fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41427706/wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yield">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

IGMS

ROAD

SAVE

SEZL

SYTA

Crude Oil Up 2%; Siyata Mobile Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 300 points on Monday.
The Dow traded down 0.70% to 42,973.32 while the NASDAQ slipped 0.17% to 18,457.71. The S&amp;P 500 also fell, dropping, 0.40% to 5,841.16.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41426981/top-4-consumer-stocks-that-may-dip-this-quarter">Top 4 Consumer Stocks That May Dip This Quarter</a>
Leading and Lagging Sectors Information technology shares jumped by 0.3% on Monday.
In trading on Monday, real estate shares fell by 1.9%.
Top Headline
Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) announced that on October 11, it modified its card processing agreement to extend the deadline for its 2025 notes from October 21 to December 23 and the early maturity date from December 31 to March 3.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Viad Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) shares shot up 14% to $40.64 after the company announced it entered into a deal to sell its GES business to Truelink Capital for $535 million.</li>
<li>Shares of Construction Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROAD#NASDAQ">ROAD</a>) got a boost, surging 12% to $83.53 after the company issued FY25 revenue above estimates. Also, Construction Partners announced it will acquire Asphalt Inc for a mix of cash $654 million in cash and 3 million in class A common stock</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares were also up, gaining 82% to $1.8294 after the company announced its next-generation SD7 Ultra series 5G mission-critical push-to-talk cellular radio handsets will be available on T-Mobile&#8217;s 5G network.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) shares dropped 11% to $200.00. Sezzle will release its third quarter results after the market close on Nov. 07.</li>
<li>Shares of Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) were down 10% to $11.29.</li>
<li>IGM Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) was down, falling 9% to $15.15.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $70.09 while gold traded up 0.2% at $2,735.00.
Silver traded up 1.8% to $33.840 on Monday, while copper fell 0.8% to $4.3500.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.66%, Germany's DAX fell 1% and France's CAC 40 fell 1.01%. Spain's IBEX 35 Index fell 0.71%, while London's FTSE 100 fell 0.48%.
Producer prices in Germany fell 1.4% year-over-year in September compared to a 0.8% decline in the prior two months.
Asia Pacific Markets
Asian markets closed mostly lower on Monday, with Japan's Nikkei 225 falling 0.07%, Hong Kong's Hang Seng Index dipped 1.57%, China's Shanghai Composite Index gaining 0.20% and India's BSE Sensex falling 0.09%.
The People&#8217;s Bank of China cut its one-year loan prime rate by 25bps to 3.1% at the October fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41427706/wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yield">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields</a></li>
</ul>

Dow Dips Over 300 Points; Viad Shares Spike Higher

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.
Shares of Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell sharply in today's pre-market trading on brokerage firm Robinhood after the company's robotaxi unveiling event late on Thursday <a href="https://www.benzinga.com/news/24/10/41285210/tesla-stock-falls-nearly-3-in-overnight-trading-on-robinhood-after-self-driving-cybercab-unveil">failed to give investors' confidence</a>.
Tesla on Thursday unveiled a two-seater Cybercab that can drive itself and a robovan with no pedals that can accommodate about 20 passengers at an event in Los Angeles on Thursday. The event, however, was thin on details with the company not divulging the cost of the robovan. Musk also said that the smaller Cybercab will join the company's autonomous taxi fleet only by 2026. The CEO further remarked that he is often optimistic about timelines, hinting at chances of delay.
Tesla shares fell 5.6% to $225.35 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) shares fell 10.6% to $0.66 in pre-market trading after dipping 5% on Thursday.</li>
<li>Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) shares declined 9.9% to $4.83 in pre-market trading.</li>
<li>A. O. Smith Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>) declined 9.4% to $78.16 in pre-market trading after the company lowered its FY24 earnings forecast.</li>
<li>Nyxoah S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) shares fell 8.3% to $8.71 in pre-market trading.</li>
<li>Indivior PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NYSE">INDV</a>) fell 7.3% to $7.40 in pre-market trading. Indivior shares dipped over 15% on Thursday after the company reported preliminary third-quarter revenue guidance and cut its FY24 net revenue guidance below estimates.</li>
<li>Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) shares dipped 7.3% to $10.60 after gaining around 8% on Thursday.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) fell 5.7% to $7.65 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41272079/top-2-health-care-stocks-that-are-ticking-portfolio-bombs">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

HSAI

INDV

LILM

NYXH

TIGR

TSLA

Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Shares of Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) rose sharply in today's pre-market trading after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41281995/aehr-test-systems-stock-climbs-after-better-than-expected-q1-results-heres-why">first-quarter financial results</a>.
Aehr Test Systems reported quarterly earnings of 7 cents per share, which beat the analyst consensus estimate of 2 cents. Quarterly revenue of $13.12 million also beat the consensus estimate of $12.17 million, according to data from Benzinga Pro.
Aehr Test Systems shares jumped 13.9% to $15.17 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) rose 68.4% to $1.0100 in pre-market trading. NIVF TW Opportunities Master Fund II, L.P. disclosed a 9.9% passive stake in NewgenIVF Group Ltd as of Oct. 4.</li>
<li>ZenaTech Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) gained 40.1% to $2.48 in pre-market trading after declining around 5% on Thursday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares rose 26.4% to $0.5930 in pre-market trading after declining 34% on Thursday.</li>
<li>LuxUrban Hotels Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) shares gained 26.1% to $0.0637 in pre-market trading after dipping 17% on Thursday. LuxUrban Hotels recently filed a prospectus to sell up to 23.63 million shares of common stock.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares surged 24.1% to $0.1014 in pre-market trading. Jet.AI shares fell around 12% on Thursday after the company announced it entered into an agreement with certain institutional investors to purchase approximately 26.6 million shares of common stock in a registered direct offering.</li>
<li>American Lithium Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMLI#NASDAQ">AMLI</a>) gained 15% to $0.9086 in pre-market trading after jumping around 18% on Thursday.</li>
<li>Kindly MD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) shares jumped 13.2% to $1.4500 in pre-market trading after declining around 7% on Thursday.</li>
<li>Burning Rock Biotech Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNR#NASDAQ">BNR</a>) rose 12.3% to $3.67 in pre-market trading. Burning Rock and Dizal secured NMPA approval for NGS-based companion diagnostic for lung cancer in China.</li>
<li>Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) gained 12% to $1.21 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares dipped 14.3% to $0.0532 in pre-market trading. Gritstone Bio shares dipped around 69% on Thursday after the company announced it voluntarily filed for Chapter 11 restructuring.</li>
<li>Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) shares fell 10.5% to $0.6611 in pre-market trading after declining around 5% on Thursday.</li>
<li>Carmell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) fell 8.8% to $0.3490 in today's pre-market trading after dipping more than 10% on Thursday.</li>
<li>Galaxy Payroll Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXG#NASDAQ">GLXG</a>) fell 8.5% to $9.42 in pre-market trading after gaining 34% on Thursday.</li>
<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) shares declined 8.2% to $1.90 in pre-market trading after dipping 21% on Thursday.</li>
<li>Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) shares declined 8.1% to $1.25 in pre-market trading. Clearmind Medicine announced it has received Institutional Review Board approval from one of its clinical sites in the U.S. for part A of its Phase I/IIa clinical trial in the United States for treating patients suffering from alcohol use disorder.</li>
<li>Momentus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTS#NASDAQ">MNTS</a>) shares fell 7.7% to $0.5850 in pre-market trading after dipping 40% on Thursday. Momentus recently announced a deal to provide launch services for NASA.</li>
<li>Innventure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INV#NASDAQ">INV</a>) shares fell 7.3% to $10.60 after gaining around 8% on Thursday.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) declined 7% to $0.3484 in pre-market trading after jumping 49% on Thursday.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell 5.6% to $225.35 in pre-market trading on brokerage firm Robinhood after the company's robotaxi unveiling event late on Thursday failed to give investors' confidence.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41272079/top-2-health-care-stocks-that-are-ticking-portfolio-bombs">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

AEHR

AKAN

AMLI

CETX

CMND

CTCX

GLXG

GRTS

JTAI

KDLY

LKCO

LUXH

MLGO

MNTS

NIVF

ZENA

Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Artificial intelligence may be a useful tool <a href="https://www.benzinga.com/news/large-cap/24/09/40942266/amazon-launches-ai-assistant-codenamed-project-amelia">for financial advisors</a>, but it will not solve their every problem.
There are three ways that financial advisors can use AI to their utmost benefit, AssetMark and Wealthmanagement.com say in a report: optimizing lead generation, segmenting the market and improving client communication.
<h2 class="wp-block-heading">Lead Generation</h2>
AI tools have proven to increase lead generation by as much as 50% and lower costs by as much as 60%, the report said.
&#8220;AI tools can build profiles based on names, publicly available data, and data from third-party vendors,&#8221; the report stated.
&#8220;These profiles can be compared to metrics for successful conversions, helping advisors focus attention on prospects who are more likely to become high-value clients.&#8221; 
<h2 class="wp-block-heading">Improved Market Segmentation</h2>
AI also helps to further segment prospects based on their unique needs, the report said.
AI and predictive analytics can also help financial advisors to quickly and accurately segment their clients based on their attributes, such as assets under management, demographics and profession.
&#8220;AI tools also help identify patterns and trends advisors can use to better understand their clients' needs and preferences,&#8221; the report said.
Read Also: <a href="https://www.benzinga.com/top-stories/24/09/40937593/oracle-cloudworld-highlights-ai-driven-tech-services-but-revenue-growth-requires-patience-analyst">Oracle CloudWorld Highlights &#8216;AI-Driven Tech Services,&#8217; But Revenue Growth Requires Patience: Analyst</a>
The ability to predict client behavior and preferences enables financial advisors to further use AI to create targeted marketing campaigns and messaging that resonate with their audience,&#8221; the report said.
&#8220;Segmentation can help advisors identify potential high-value clients, allowing them to pursue leads strategically and allocate their marketing resources more efficiently by aligning them with key growth drivers.&#8221;
<h2 class="wp-block-heading">Better Communication</h2>
AI tools can also help advisors to prioritize and target their communications with their clients, the report said.
&#8220;Predictive tools help advisors reach out to clients proactively to provide solutions at the right time — sometimes even before clients realize they need them,&#8221; it said.
&#8220;Getting the right information to the right clients at the right time is often the key to ensuring clients take action.&#8221;
AI can also give advisors a hand at creating engaging content for clients and also help them to write emails, social media content and website copy for clients more efficiently.
&#8220;Advisors can gather questions from clients, for instance, and use AI to generate custom content based on their inquiries that are specific to niche client needs,&#8221; the report said.
<h2 class="wp-block-heading">AI Tools &#8216;May Be Useful To Some Extent&#8217;</h2>
But AI is not the end-all, be-all solution for financial advisors, Canadian financial planner Jason Pereira <a href="https://www.kitces.com/blog/generative-ai-artificial-intelligence-advisor-technology-chat-gpt-software-innovation/">wrote</a> for Kitces.
&#8220;It may be helpful for advisors to take a realistic approach to the value that AI tools will provide, especially in an environment where technology providers often make bold claims about their solutions&#8217; ability to save time and reduce costs,&#8221; he wrote.
&#8220;Some of the capabilities of today&#8217;s AI tools (e.g., automating workflows or retrieving client information using a chatbot) may be useful to some extent, but if the processes that they replace don&#8217;t take that much time to begin with, then the tools&#8217; benefits may not justify the additional cost to implement them.&#8221;
It will most likely take 10 years for AI tools to develop to the point where they can help financial advisors in a meaningful way, such as reducing headcount by 50%, he said.
Price Action: Financial Advisory firms trended upward into Thursday&#8217;s mid-afternoon trading.
<ul>
<li>Franklin Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) went up 2.1% to $20.82.</li>
<li>Invesco Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INV#NYSE">INV</a>) gained 3.1% to $17.27</li>
<li>T. Rowe Price Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) picked up 2.45% to $110.78</li>
<li>AllianceBernstein Holding L.P. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) gained 1.68% to $35.18</li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40942923/short-seller-targets-verint-systems-stock-as-ai-threat-emerges-the-future-is-certainly-not-verint">Short Seller Targets Verint Systems Stock As AI Threat Emerges: &#8216;The Future Is Certainly Not Verint&#8217;</a></li>
</ul>
Image: Midjourney

Tech

TROW

Top 3 AI Uses For Financial Advisors Flagged In Report: Financial Planner Says Beware, Technology Is No Cure-All

Inovio Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ino#NASDAQ">INO</a>) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters <a href="https://www.reuters.com/article/brief-inovio-says-covid-19-vaccine-candi/brief-inovio-says-covid-19-vaccine-candidate-to-enter-phase-2-3-study-in-sept-conf-call-idUSFWN2FC1AJ">reported</a>.
Coronavirus Vaccine Update:&nbsp;The Pennsylvania-based drugmaker had previously estimated it would begin the phase two and three trials during summer this year.
Inovio said during the earnings call it&nbsp;was exploring partnerships beyond the United States and Europe for its vaccine candidate, and expected repetitive revenue similar to those&nbsp;from the flu vaccine.
The company&nbsp;reiterated its previous estimate of&nbsp;producing one million doses this year and 100 million by 2021, and said it&nbsp;planned to obtain additional external funding to scale up the manufacturing of the vaccine.&nbsp;
Inovio claimed&nbsp;the vaccine could be stored at room temperature for over a year and in normal refrigeration for up to 5 years.&nbsp;
The pricing of the drug would be similar to those of other companies. Rival Moderna Inc&rsquo;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) is reportedly the steepest priced vaccine at between <a href="https://www.benzinga.com/general/biotech/20/07/16820821/moderna-looking-to-price-its-coronavirus-vaccine-at-50-60-significantly-above-rivals-ft">$50 to $60 per course</a>.
Q2 Earnings Miss:&nbsp;Inovio <a href="http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Reports-Second-Quarter-2020-Financial-Results-Provides-DNA-Medicines-Clinical-Program-Mid-Year-Update/default.aspx">posted</a> a second-quarter loss of 83 cents per share, compared with loss of 30 cents per share in the same period a year earlier.&nbsp;
Total revenue was $267,000, compared with $136,000 for the same period in 2019.
Factset analysts had predicted a loss of 17 cents per share and revenue of $2.6 million, MarketWatch&nbsp;<a href="https://www.marketwatch.com/story/inovio-pharma-stock-fluctuates-after-results-vaccine-update-2020-08-10">reported</a>.
The company attributed the net loss to a derivatives liability, which mandates revaluation at each reporting period. Without this expense, the net loss per share would have been 20 cents,&nbsp;it claimed.
COVID-19 Vaccine Competitors:&nbsp;Moderna, Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>), Pfizer Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) and its partner BioNTech SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bntx#NASDAQ">BNTX</a>) are all nearing or already conducting <a href="https://www.benzinga.com/news/20/07/16664873/johnson-johnson-says-late-stage-coronavirus-vaccine-trials-moved-ahead-to-september">late-stage human trials</a> for their COVID-19 vaccine candidates.&nbsp;&nbsp;
INO Price Action:&nbsp;Inovio shares traded 6.8% lower at $17.70 in the after-hours session after reporting the earnings.

Biotech

Health Care

General

BNTX

MRNA

Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September

Innovaro, Inc. (NYSE MKT: INV) has received notice, dated December 4, 2012, that the NYSE MKT LLC intends to proceed with an application to the United States Securities and Exchange Commission to remove the Company's common stock from listing on the NYSE MKT. This determination, which the Company intends to appeal, was made in light of the NYSE MKT's position that the Company is not in current compliance with certain standards for continued listing on the NYSE MKT. 

Specifically, the NYSE MKT believes that the Company is not in compliance with the following sections of the NYSE MKT Company Guide: 

Section 1003(a)(ii) of the NYSE MKT Company Guide in that the Company reported stockholders' equity of less than $4,000,000 at September 30, 2012 and losses from continuing operations and/or net losses in its three out of its four most recent fiscal years ended December 31, 2011; 
Section 1003(a)(iii) of the NYSE MKT Company Guide in that the Company reported stockholders' equity of less than $6,000,000 at June 30, 2012 and had losses from continuing operations and/or net losses in each of its five consecutive fiscal years ended December 31, 2011; and 
Section 1003(a)(iv) of the NYSE MKT Company Guide in that the Company has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the NYSE MKT, that the Company will be able to continue operations and/or meet its obligations as they mature. 
In accordance with Sections 1009(d) and 1203 of the NYSE MKT Company Guide, the Company plans to appeal the NYSE MKT's determination by requesting a hearing before a Listing Qualifications Panel. There can be no assurance that the Company's request for continued listing will be granted or that, if granted, the Company will be able to continue to meet the minimum listing requirements.

Innovaro Receives Delisting Notification from the NYSE MKT   

Innovaro (NYSEAMEX: INV) reports third-quarter EPS of $-0.05.

Innovaro Reports Q3 EPS $-0.05

Innovaro, Inc. (NYSE MKT: INV), The Innovation Solutions Company, announces
partnership with DataMentors.

Innovaro and DataMentors LLC have entered into an agreement which gives
DataMentors the ability to integrate LaunchPad Listen into their DataFuse
solution. The new option to DataFuse, called “SocialAppeal”, will be powered
by Innovaro's LaunchPad Listen and will provide sentiment and analytical
analysis of postings on social media sites. SocialAppeal is an innovative
solution, one of the first tools in the market today to automatically
integrate social intelligence into a marketing database. This new offering by
DataMentors will further strengthen their leadership position in the data
quality and management space.

Innovaro Announces Strategic Partnership with DataMentors

Innovaro, Inc. (NYSE: <a class="ticker" href="/stock/inv#NYSE">INV</a>), The Innovation Solutions Company, today
announced it has completed the spinoff of its Strategos Division as part of
its continuing transition to a software and information led innovation
solutions business. Since its origins in 1996, Strategos has consulted with
corporate clients around the world, including 25 of the 30 Dow Jones
Industrial Average companies, to help them build deep innovation capabilities
and develop and execute creative, innovative strategies.

Asset Sales

Innovaro Announces the Spinoff of the Strategos Consulting Division; Will Make Cash Payments of About $150K

Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:

Vringo

Shares of Vringo (NASDAQ: <a class="ticker" href="/stock/vrng#NASDAQ">VRNG</a>), the New York-based developer of video ringtones and holder of mobile and Internet search patents, rose 39.16% Wednesday on 7 times average volume.

Vringo received a favorable court ruling on Wednesday, as the judge overseeing the company's patent dispute with Google denied Google's request for a summary judgment. The parties were ordered to engage in settlement discussions between United States magistrate, Judge Lawrence R. Leonard at 10:30am, Tuesday October 9, 2012. 

Vringo closed at $4.30 on Wednesday.

Biolase

Shares of Biolase (NASDAQ: <a class="ticker" href="/stock/biol#NASDAQ">BIOL</a>), the Irvine, CA dental laser company, rose 33.73% Wednesday on 49 times average volume.

Biolase, the world's leading dental laser manufacturer and distributor, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and Conformité Européene Mark approval for its EPIC 10™ diode soft tissue laser. BIOLASE initiated commercial sales in the final days of the third quarter of 2012 throughout the European Union and in those Asian and Latin American countries that recognize the CE Mark. The Company received notification of clearance from the FDA on October 1, 2012, and immediately began offering the EPIC 10 for sale in the U.S.

Biolase closed at $2.22 on Wednesday.

Innovaro

Innovaro (NYSE: <a class="ticker" href="/stock/inv#NYSE">INV</a>), the Tampa, FL consulting company, rose 28.57% Wednesday on 5 times average volume.

In an 8-K filing on Wednesday, Innovaro reported that on September 27, 2012, they entered into a securities purchase agreement with JJJ Family LLLP pursuant to which they agreed to issue to the Buyer, in a registered offering, 531,915 shares of common stock priced at $0.47 per share along with a Series B warrant to purchase up to 531,915 shares of common stock with an exercise price of $0.47 per share of common stock. The offering will raise gross proceeds to Innovaro of $250,000 before offering expenses.

The Series B warrant will be exercisable for a five-year period commencing on the six month anniversary of the date of its issuance.

The Securities Purchase Agreement provides the Buyer with the right to participate in future offerings of securities, in an amount up to $250,000 in each offering, for a period of one year after the date of the sale.

Innovaro closed at $0.63 on Wednesday.

The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment.

Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

Long Ideas

Short Ideas

Small Cap

Global

After-Hours Center

BIOL

VRNG

Benzinga's Microcap Movers for Wednesday October 3, 2012

Innovaro, Inc. (NYSE: <a class="ticker" href="/stock/inv#NYSE">INV</a>), The Innovation Solutions 
 Company, announced today that on August 24, 2012, the Company received 
 notice that the NYSE MKT LLC (the "Exchange") approved the Company's 
 plan for regaining compliance with Section&nbsp;1003(a)(iv) of the Exchange 
 Company Guide by November 30, 2012 (the “Financial Impairment Plan”).
 Previously, on June 12, 2012, the Exchange notified the Company that it 
 was not in compliance with Section 1003(a)(iv) of the Exchange Company 
 Guide in that the Exchange believed that the Company had sustained 
 losses which are so substantial in relation to its overall operations or 
 its existing financial resources, or its financial condition had become 
 so impaired that it appeared questionable, in the opinion of the 
 <a href="http://www.benzinga.com/pressreleases/12/08/b2869245/innovaro-inc-financial-plan-approved-by-nyse-mkt">See full press release</a>

Financing

Innovaro Financial Plan Approved by NYSE MKT 

Innovaro, Inc. (NYSE: <a class="ticker" href="/stock/inv#NYSE">INV</a>), The Innovation Solutions Company announces that it has reached additional agreements with leading Korean communications company KT to provide consulting services through Strategos, Innovaro's consulting services division. 

Innovaro, under these agreements, will assist the client as they continue the company-wide deployment of innovation tools, skills, structures, and processes. The current project phase focuses on embedding the new innovation capability in the company's processes and management systems as well as enhancing client employees' abilities to apply innovation techniques in their own jobs and conduct small-scale, low-risk experiments to test new ideas. In addition, KT has executed a LaunchPad license to allow deployment of the LaunchPad eLearning Streams, facilitating the ongoing training and development of their personnel. 

These agreements represent the fifth phase of the relationship, which has been ongoing since April of 2010. This phase is planned for completion at the conclusion of the first half of 2012.

Contracts

Innovaro, Inc. Enters Fifth Phase Projects with KT, the Leading Telecom Operator in Asia   

Innovaro Filed Amended 10-Q; Reports 2011 EPS $(0.31); Revenue $14.9M

Comments

Innventure

ニュース

最新ニュース Innventure (NASDAQ:INV) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル